Bacillus anthracis-derived edema toxin (ET) counter-regulates movement of neutrophils and macromolecules through the endothelial paracellular pathway

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Nguyen, Chinh ^a   Feng, Chiguang ^b   Zhan, Min ^b   Cross, Alan S ^b   Goldblum, Simeon E ^b  

^a Building 2   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLUS ANTHRACIS EDEMA TOXIN; BACTERIAL TOXIN; CARBON 14; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTHRAX TOXIN; BACTERIAL ANTIGEN; CARBON;

ARTICLE; BACILLUS ANTHRACIS; BACTERIAL VIRULENCE; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; NEUTROPHIL; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; CELL CULTURE; CELL MOTION; DRUG EFFECT; ENDOTHELIUM CELL; ISOTOPE LABELING; MACROMOLECULE; METABOLISM; PATHOGENICITY; PHYSIOLOGY;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS);

ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CARBON RADIOISOTOPES; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-8; ISOTOPE LABELING; MACROMOLECULAR SUBSTANCES; NEUTROPHILS;

EID: 84855473835     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-2     Document Type: Article

References (50)

1. Manipulation of host signalling pathways by anthrax toxins. Turk BE, Biochem J 2007 402 405 417 (Pubitemid 46423878)
2. The adenylate cyclase toxins. Ahuja N, Kumar P, Bhatnagar R, Crit Rev Microbiol 2004 30 187 196 (Pubitemid 39141923)
3. Cell entry and cAMP imaging of anthrax edema toxin. Dal MF, Tonello F, Ladant D, Zornetta I, Zamparo I, Di BG, et al. EMBO J 2006 25 5405 5413 (Pubitemid 44764149)
4. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection. Bonuccelli G, Sotgia F, Frank PG, Williams TM, de Almeida CJ, Tanowitz HB, et al. Am J Physiol Cell Physiol 2005 288 1402 C1410
5. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Scobie HM, Rainey GJ, Bradley KA, Young JA, Proc Natl Acad Sci USA 2003 100 5170 5174 (Pubitemid 36542677)
6. Structural and kinetic analyses of the interaction of anthrax adenylyl cyclase toxin with reaction products cAMP and pyrophosphate. Guo Q, Shen Y, Zhukovskaya NL, Florian J, Tang WJ, J Biol Chem 2004 279 29427 29435 (Pubitemid 38915822)
7. Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. Hong J, Doebele RC, Lingen MW, Quilliam LA, Tang WJ, Rosner MR, J Biol Chem 2007 282 19781 19787 (Pubitemid 47100121)
8. Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. Hoover DL, Friedlander AM, Rogers LC, Yoon IK, Warren RL, Cross AS, Infect Immun 1994 62 4432 4439 (Pubitemid 24301974)
9. Bacillus anthracis edema toxin impairs neutrophil actin-based motility. Szarowicz SE, During RL, Li W, Quinn CP, Tang WJ, Southwick FS, Infect Immun 2009 77 2455 2464
10. cAMP signaling in leukocyte transendothelial migration. Lorenowicz MJ, Fernandez-Borja M, Hordijk PL, Arterioscler Thromb Vasc Biol 2007 27 1014 1022 (Pubitemid 46641986)
11. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N, et al. Mol Cell Biol 2005 25 136 146 (Pubitemid 40039806)
12. Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. Kooistra MR, Corada M, Dejana E, Bos JL, FEBS Lett 2005 579 4966 4972 (Pubitemid 41242837)
13. Rap1 regulates E-cadherin-mediated cell-cell adhesion. Price LS, Hajdo-Milasinovic A, Zhao J, Zwartkruis FJ, Collard JG, Bos JL, J Biol Chem 2004 279 35127 35132 (Pubitemid 39100508)
14. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor. Rangarajan S, Enserink JM, Kuiperij HB, de RJ, Price LS, Schwede F, et al. J Cell Biol 2003 160 487 493 (Pubitemid 36254387)
15. Epac1-Rap1 signaling regulates monocyte adhesion and chemotaxis. Lorenowicz MJ, van GJ, de BM, Hordijk PL, Fernandez-Borja M, J Leukoc Biol 2006 80 1542 1552 (Pubitemid 44904993)
16. Epac-selective cAMP analog 8-pCPT-2'-O-Me-cAMP as a stimulus for Ca2 + -induced Ca2+ release and exocytosis in pancreatic beta-cells. Kang G, Joseph JW, Chepurny OG, Monaco M, Wheeler MB, Bos JL, et al. J Biol Chem 2003 278 8279 8285 (Pubitemid 36800574)
17. Cutting edge: macrophage inhibition by cyclic AMP (cAMP): differential roles of protein kinase A and exchange protein directly activated by cAMP-1. Aronoff DM, Canetti C, Serezani CH, Luo M, Peters-Golden M, J Immunol 2005 174 595 599 (Pubitemid 40094248)
18. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Firoved AM, Miller GF, Moayeri M, Kakkar R, Shen Y, Wiggins JF, et al. Am J Pathol 2005 167 1309 1320 (Pubitemid 41541417)
19. Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. Moayeri M, Haines D, Young HA, Leppla SH, J Clin Invest 2003 112 670 682 (Pubitemid 38057708)
20. Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo. Comer JE, Chopra AK, Peterson JW, Konig R, Infect Immun 2005 73 8275 8281 (Pubitemid 41740317)
21. Effects of anthrax toxin components on human neutrophils. O'Brien J, Friedlander A, Dreier T, Ezzell J, Leppla S, Infect Immun 1985 47 306 310 (Pubitemid 15194628)
22. Anthrax toxin components stimulate chemotaxis of human polymorphonuclear neutrophils. Wade BH, Wright GG, Hewlett EL, Leppla SH, Mandell GL, Proc Soc Exp Biol Med 1985 179 159 162 (Pubitemid 15014832)
23. Index case of fatal inhalational anthrax due to bioterrorism in the United States. Bush LM, Abrams BH, Beall A, Johnson CC, N Engl J Med 2001 345 1607 1610 (Pubitemid 33126840)
24. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, et al. Emerg Infect Dis 2001 7 933 944 (Pubitemid 33115771)
25. Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Guarner J, Jernigan JA, Shieh WJ, Tatti K, Flannagan LM, Stephens DS, et al. Am J Pathol 2003 163 701 709 (Pubitemid 36909431)
26. Pathology of inhalational anthrax infection in the african green monkey. Twenhafel NA, Leffel E, Pitt ML, Vet Pathol 2007 44 716 721 (Pubitemid 47451244)
27. cAMP protects endothelial barrier function independent of inhibiting MLC20-dependent tension development. Moy AB, Bodmer JE, Blackwell K, Shasby S, Shasby DM, Am J Physiol 1998 274 1024 L1029
28. Expression of PKA inhibitor (PKI) gene abolishes cAMP-mediated protection to endothelial barrier dysfunction. Lum H, Jaffe HA, Schulz IT, Masood A, RayChaudhury A, Green RD, Am J Physiol 1999 277 580 C588
29. cAMP protects endothelial barrier functions by preventing Rac-1 inhibition. Waschke J, Drenckhahn D, Adamson RH, Barth H, Curry FE, Am J Physiol Heart Circ Physiol 2004 287 2427 H2433
30. Dominant role of cAMP in regulation of microvessel permeability. He P, Zeng M, Curry FE, Am J Physiol Heart Circ Physiol 2000 278 1124 H1133
31. Microvascular permeability and number of tight junctions are modulated by cAMP. Adamson RH, Liu B, Fry GN, Rubin LL, Curry FE, Am J Physiol 1998 274 1885 H1894
32. Permeability of human endothelial monolayers: effect of vasoactive agonists and cAMP. Casnocha SA, Eskin SG, Hall ER, McIntire LV, J Appl Physiol 1989 67 1997 2005 (Pubitemid 20039411)
33. Molecular mechanisms mediating protective effect of cAMP on lipopolysaccharide (LPS)-induced human lung microvascular endothelial cells (HLMVEC) hyperpermeability. Bogatcheva NV, Zemskova MA, Kovalenkov Y, Poirier C, Verin AD, J Cell Physiol 2009 221 750 759
34. High and low affinity Ca2+ binding to the sarcoplasmic reticulum: use of a high-affinity fluorescent calcium indicator. Chiu VC, Haynes DH, Biophys J 1977 18 3 22 (Pubitemid 8086372)
35. A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Shaywitz AJ, Greenberg ME, CREB, Annu Rev Biochem 1999 68 821 861 (Pubitemid 29449210)
36. cAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression. Grader-Beck T, van Puijenbroek AA, Nadler LM, Boussiotis VA, Blood 2003 101 998 1006 (Pubitemid 36139372)
37. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. Crawford MA, Aylott CV, Bourdeau RW, Bokoch GM, J Immunol 2006 176 7557 7565 (Pubitemid 43849059)
38. Contributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis. Tessier J, Green C, Padgett D, Zhao W, Schwartz L, Hughes M, et al. Infect Immun 2007 75 1895 1903 (Pubitemid 46559459)
39. An adenosine 3',5'-monophosphate-dependant protein kinase from rabbit skeletal muscle. Walsh DA, Perkins JP, Krebs EG, J Biol Chem 1968 243 3763 3765
40. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, et al. Nature 1998 396 474 477 (Pubitemid 28553318)
41. A family of cAMP-binding proteins that directly activate Rap1. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, et al. Science 1998 282 2275 2279 (Pubitemid 29004080)
42. Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Cullere X, Shaw SK, Andersson L, Hirahashi J, Luscinskas FW, Mayadas TN, Blood 2005 105 1950 1955 (Pubitemid 40731777)
43. Rap1 GTPase inhibits leukocyte transmigration by promoting endothelial barrier function. Wittchen ES, Worthylake RA, Kelly P, Casey PJ, Quilliam LA, Burridge K, J Biol Chem 2005 280 11675 11682 (Pubitemid 40418482)
44. Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection. Birukova AA, Zagranichnaya T, Alekseeva E, Bokoch GM, Birukov KG, J Cell Physiol 2008 215 715 724 (Pubitemid 351632693)
45. TLR4 signaling is coupled to SRC family kinase activation, tyrosine phosphorylation of zonula adherens proteins, and opening of the paracellular pathway in human lung microvascular endothelia. Gong P, Angelini DJ, Yang S, Xia G, Cross AS, Mann D, et al. J Biol Chem 2008 283 13437 13449
46. Mobilization of neutrophil sialidase activity desialylates the pulmonary vascular endothelial surface and increases resting neutrophil adhesion to and migration across the endothelium. Sakarya S, Rifat S, Zhou J, Bannerman DD, Stamatos NM, Cross AS, et al. Glycobiology 2004 14 481 494 (Pubitemid 38868263)
47. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis. Goldblum SE, Van Epps DE, Reed WP, J Clin Invest 1979 64 255 264 (Pubitemid 9216541)
48. Runt-related gene 2 in endothelial cells: inducible expression and specific regulation of cell migration and invasion. Sun L, Vitolo M, Passaniti A, Cancer Res 2001 61 4994 5001 (Pubitemid 32681526)
49. Protein kinase A and chromosomal stability. Matyakhina L, Lenherr SM, Stratakis CA, Ann N Y Acad Sci 2002 968 148 157 (Pubitemid 34721878)
50. TNF-alpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. Angelini DJ, Hyun SW, Grigoryev DN, Garg P, Gong P, Singh IS, et al. Am J Physiol Lung Cell Mol Physiol 2006 291 1232 L1245